Targeted therapy and immunotherapy improve outcomes in rare thyroid cancer

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC). Findings from the Phase II single center study published today in JAMA Oncology.

Basecamp raises $60M to travel the globe and fill AI data gaps, signs deal with David Liu

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 10, 2024

Forum Launches with $5M for Virtual Peer Support Groups to Help People Navigate Life’s Challenges

Rajiv Kumar, MD, Co-Founder & CEO (Left) and Lee Pichette Co-Founder, President & COO (Right) What You Should Know: – Forum, a peer support group

November 10, 2023

Metformin Use Linked to Fewer Asthma Attacks

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the

November 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.